MedTrace Logo

Rectal Versus Intramuscular Diclofenac for Pain Relief Following Caesarean Section

NCT06845930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-02-25

No results posted yet for this study

Summary

Caesarean section (CS) is one of the commonest major Obstetric surgeries worldwide and its rate has markedly increased globally. Pain control is an integral part of enhancement of recovery after caesarean section and NSAIDs have been used in combination with opioids for post-operative pain management in recent times. There are sparse data on maternal satisfaction with suppository diclofenac or any data from our centre that compared the intramuscular and rectal routes of diclofenac administration. Hence this study was conceived to compare the efficacy of rectal diclofenac and intramuscular diclofenac as an adjunct to intramuscular pentazocine in the management of post-operative pain in women who have elective caesarean section.

Conditions

  • Painrelief
  • Postoperative

Interventions

DRUG

Rectal Diclofenac

Rectal diclofenac, 100mg administered immediately after skin closure then 12 hourly for 24 hours.

DRUG

Intramuscular diclofenac

Intramuscular diclofenac, 7mg administered immediately after skin closure then 12 hourly for 24 hours.

Sponsors & Collaborators

  • Assumpta Nnenna Nweke

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2021-09-18
Completion
2021-09-18

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06845930 on ClinicalTrials.gov